Select language:  
1800 620 420
Close menu

From PhD in Melbourne to postdoc in New York

New York-based, Aussie researcher Matt Witkowski has his sights set on improving the effectiveness of CAR T-cell therapy.

  • Acute lymphoblastic leukaemia
  • Research
Read more
Matthew Witkowski

Research aims to improve QOL by decreasing treatment toxicity

Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.

  • Myeloma
  • Research
Read more
Kate van Dyke

Expert Series: AProf. David Ross on how clinical trials are critical to finding curative therapies for MPN

Professor David Ross discusses the "massive explosion" of recent clinical trial activity in MPN.

  • Clinical trials
  • Interviews with experts
  • Myeloproliferative neoplasms
  • Research
Read more
Dr David Ross and others in Tokyo

Improving outcomes for Australians with an MPN 

Dr Liesl Butler is investigating the gene mutations and biological pathways that lead to the development of MPN.

  • Myeloproliferative neoplasms
  • Research
Read more
Gene

Q&A: Dr Peter Diamond – our head of research

Head of the Leukaemia Foundation’s National Research Program, Dr Peter Diamond discusses his role, priorities for the program, and exciting breakthroughs coming up in blood cancer research. 

  • Research
Read more
Dr Peter Diamond

Searching for “more effective and gentler” therapies for AML

The Professor of Harvard University’s Department of Stem Cell and Regenerative Biology spoke with us about why he chose this line of work, and his research objectives.

  • Acute myeloid leukaemia
  • Research
Read more
David-Scadden-therapies-for-AML

 Adding the microenvironment to the AML therapy mix improves efficacy   

Associate Professor Ingrid Wrinkler's findings have "opened up a whole new field".

  • Acute myeloid leukaemia
  • Research
Read more
Ingrid Winker and Valerie Barbier

Leukaemia Foundation invests almost $3m in innovative AML research

Seven research projects that are part of the National Research Program focus on better understanding and treating acute myeloid leukaemia (AML). 

  • Acute myeloid leukaemia
  • Research
Read more
Dr Laura Bray

Understanding MDS and the biological processes driving treatment response

Dr Steven Lane hopes to understand how myelodysplasia (MDS) forms from normal cells.

  • Myelodysplastic syndromes
  • Research
Read more
Steven Lane in the lab

What’s CAR T-cell therapy?

Dr Bruce Levine explains how it works and why.

  • Research
  • Treatments and side-effects
Read more
Bruce Levine